Suzhou, China

Xuejun Yu

This inventor holds 1 USPTO granted patent. Top assignee: Suzhou Bioswan Laboratories, Co., Ltd.. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Xuejun Yu. Retrieved from https://idiyas.com/inventor/xuejun-yu-afwm2k8s

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Xuejun Yu: Innovator in Monoclonal Antibody Research

Introduction

Xuejun Yu is a prominent inventor based in Suzhou, China. He has made significant contributions to the field of biotechnology, particularly in the development of monoclonal antibodies. His work is crucial for advancements in medical diagnostics and therapies.

Latest Patents

Xuejun Yu holds a patent titled "Monoclonal Antibody for Detection of CAR-T Cells, Kit and Application." This innovative patent addresses the detection of CAR-T cells, which are vital in cancer immunotherapy. His research in this area has the potential to enhance the effectiveness of cancer treatments.

Career Highlights

Xuejun Yu is currently employed at Suzhou Bioswan Laboratories, Co., Ltd. His role at the company allows him to apply his expertise in monoclonal antibody research. With a focus on practical applications, he aims to bridge the gap between research and real-world medical solutions.

Collaborations

Xuejun collaborates with notable colleagues, including Liang Da and Guowei Wei. Their combined efforts contribute to the advancement of research in the field of biotechnology.

Conclusion

Xuejun Yu's innovative work in monoclonal antibodies exemplifies the impact of research on medical science. His contributions are paving the way for improved diagnostic and therapeutic techniques in cancer treatment.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…